Following fields are empty!
Theranostics
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Therapeutic Innovation & Regulatory Science
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELib-konsortion solmima sopimus Springer Naturen kanssa vuosille 2026-2027 sisältää vastaaville kirjoittajille oikeuden julkaista artikkeleita avoimena ilman lisämaksua Springer Compact -kokoelman hybridilehdissä sopimuskauden aikana. Julkaista voi myös edellisen ja nykyisen sopimuskauden aikana hybridistä täysin avoimeksi muuttuvassa nimekkeessä, joka sisältyy lehtilistaan.FinELib consortium’s agreement with Springer Nature for the years 2026-2027 includes open access publishing for corresponding authors in Springer's hybrid titles in Compact collection without extra charge during the agreement term. Additionally publishing is possible in titles included in the list that transitioned from hybrid to fully OA during the previous agreement term or do so during the current agreement term.
- Ohjeita julkaisemiseen FinELibin sivuilla Artikkelin julkaiseminen avoimena Springer Compact lehdissä
- Springer Nature Link Journal Finder Hae tai selaa Springer Naturen lehtiä sopivan lehden löytämiseksi artikkelisi julkaisemiseen
- Open Access Agreements in Finland Tietoa kirjoittajille
- Instructions on publishing on FinELib's pages Open Access Publishing in Springer Compact Journals
- Springer Nature Link Journal Finder Search or browse journals across all of Springer Nature's brands to discover the perfect journal for you
- Open Access Agreements in Finland Information for Authors
Value in Health Regional Issues
Value in Health Regional Issues (ViHRI) is a new scientific journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to encourage and enhance the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions in Asia, Latin America, Central & Eastern Europe, Western Asia, and Africa.
Compliant Options - Provided by Journal Checker Tool
Go ahead and submit. Remember to select a CC BY licence to ensure compliance.
Select the open access publishing option with a CC BY license to ensure compliance.
Go ahead and submit. Remember to select a CC BY license to ensure compliance.
Following acceptance, please deposit your author accepted manuscript in a repository without embargo.
Your funder’s grant conditions set out how you can retain sufficient rights to self-archive the Author Accepted Manuscript in any OA repository. Publishing fees do not apply with this route.
Unfortunately, this journal has no Plan-S compliant options - Provided by Journal Checker Tool
Institutional Agreement
FinELibin ja Elsevierin vuodelle 2026 solmiman sopimuksen perusteella vastaavat kirjoittajat voivat julkaista avoimia artikkeleita ilman APC-maksua (article processing charge) sopimuksen piiriin kuuluvissa Elsevierin hybridi- ja hybrideistä gold open access -lehdiksi muuttuneissa lehdissä.
Huom! Tutkijat voivat julkaista ilman APC-maksua sopimukseen kuuluvissa Freedom-lehdissä FinELibin sivuilla mainituilla ehdoilla 31.12.2026 asti.
Tutkijoille maksuttomien avointen artikkelien määrän arvioitiin loppuvan elokuun loppuun mennessä. Elsevier on poistanut avointen artikkelien kiintiön Freedom-lehdistä. Julkaisemisen ehtoihin ei ole tullut muutoksia.
Under the agreement for 2026 between FinELib and Elsevier, corresponding authors can publish open access articles without an APC (article processing charge) in eligible Elsevier hybrid journals and hybrid journals that have transitioned to gold open access.
Att! Researchers can publish without an APC fee in the Freedom journals covered by the agreement under the conditions stated in FinELib webpages until 31 December 2026.
The number of free open access articles available to researchers had been estimated to run out by the end of August. Elsevier has removed the quota for open access articles. No changes have been made to the publishing conditions.
- Ohjeita julkaisemiseen FinELibin sivuilla: Artikkelin julkaiseminen avoimena Elsevierin lehdissä
- Instructions on publishing on FinELib's pages: Open Access Publishing in Elsevier Journals